18 assets in Thrombocytopenia

Therapeutic assets addressing Thrombocytopenia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Recombinant Human Thrombopoietin Thrombocytopenia	Sun Yat-sen University	P4	BBB (78)
Eltrombopag Thrombocytopenia	Institute of Hematology & Blood Diseases Hospital, China	P4	BB (71)
Avatrombopag Thrombocytopenia	Second Affiliated Hospital of Guangzhou Medical University	P4	BB (70)
Hetrombopag Thrombocytopenia	Sun Yat-sen University	P3	BB (69)
Romiplostim Thrombocytopenia	Ain Shams University	P3	BB (65)
Herombopag Thrombocytopenia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Herombopag Olamine Tablets Thrombocytopenia	Fujian Cancer Hospital	P2	CCC (53)
Interleukin-11 Thrombocytopenia	Jun wang	P2	CCC (53)
Rafutrombopag Thrombocytopenia	RenJi Hospital	P2	CCC (53)
Tretinoin Thrombocytopenia	Peking University People's Hospital	P2	CCC (53)
Vipivotide Tetraxetan Thrombocytopenia	M.D. Anderson Cancer Center	P2	CCC (53)
pn20 Thrombocytopenia	Chongqing Peg-Bio Biopharm Co., Ltd.	P1	CC (46)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes Thrombocytopenia	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1	CC (43)
Aspirin Thrombocytopenia	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A	D (30)
Cilostazol Thrombocytopenia	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A	D (30)
Clopidogrel Thrombocytopenia	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A	D (30)
Dipyridamole Thrombocytopenia	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A	D (30)